Chicago, Illinois – June 9, 2020 – To help empower clinicians and patients in their fight against breast cancer, GE Healthcare today announced the Food and Drug Administration’s 510(k) clearance of Pristina Serena Bright™*, the healthcare industry’s first contrast-enhanced mammography solution for
https://www.genewsroom.com/press-releases/ge-healthcare-receives-fda-clearance-industry%E2%80%99s-first-contrast-enhanced-mammography